Like pls

Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar

Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food a
Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论

  • 推荐
  • 最新
empty
暂无评论